California’s decision to restrict the use of the title “doctor” in clinical settings underscores a growing disconnect between healthcare policy and the realities of modern care delivery. In an op-ed, health policy professor and former Virginia legislator, Dawn M. Adams, DNP, and Marissa J. Levine, MD, a public health physician and former Virginia health commissioner, argue that rigid physician-centric hierarchies no longer reflect how patients actually receive care.

The BENEFIT-HF trial, scheduled to begin enrollment in the months ahead, could significantly increase the number of patients eligible for CVRx's Barostim therapy.

One of Massachusetts’ largest private radiology groups, CRA won the business after Monadnock Community Hospital, Peterborough, launched a competitive search process. 

Anteris Technologies is known for its biomimetic transcatheter heart valve, the DurAVR THV System. The device is the first of its kind and has gained considerable attention as the TAVR market continues to grow.

Abbott pointed to double-digit growth for its Navitor TAVR valve as well as big gains for the TriClip and MitraClip devices. The company also shared positive sales figures for its EP, heart failure and rhythm management portfolios. 

Last month, the Republican and Democratic Doctors Caucuses sent an informal request to medical societies, seeking ways to reform Medicare’s push toward value-based care. 

UnitedHealth Group CEO Stephen Hemsley is expected to make the announcement in front of Congress, where he will also offer other policy solutions. The company said it’s still working out details on how to best distribute its profits to customers. 

Johnson & Johnson reported $24.6 billion in sales for the fourth quarter of 2025, up 9.1% from the previous year. On an earnings call with investors, the company's CEO sang the praises of the company's cardiovascular health division.